Functional expression of the multidrug resistance protein P-glycoprotein (P-gp) in Escherichia coli is providing an appropriate system for structure/function studies and might provide an invaluable tool to screen potential P-gp substrates and inhibitors. The major problem encountered in such studies, however, is the impermeability of the outer membrane of Gram-negative 
chemosensitizers. These reversal agents are also unrelated structurally to each other and include calcium channel blockers such as verapamil (14) , calmodulin inhibitors (15) , immunosuppressants (16) , reserpine (17) , the anti-arrhythmic agent quinidine (18) , and lysosomotropic amines such as chloroquine (19) . The ability of mdr genes to directly confer MDR has been established in transfection experiments (8, 20) , and its transport activity has been investigated with whole cells, with plasma membrane preparations, and also recently with reconstituted liposomes (21, 22) and with heterologous secretory vesicles from yeast (23) . In this regard, we believe that heterologous expression systems in microorganisms may be advantageous for studying P-gp and other membrane proteins (for review see ref. 24) .
Heterologous expression systems for P-gp studies in yeast (25, 26) and in insect cells (11, 27) have been developed in recent years. In addition, it has also been shown that the mouse Mdrl protein can be expressed functionally in Escherichia coli (28) . Briefly, the protein expressed in E. coli is found in the membrane in relatively stable form with an apparent molecular
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weight similar to that of the unglycosylated P-gp (120-140 kDa). The protein is recognized by monoclonal antibodies directed against the putative nucleotide binding fold of P-gp (C219). Cells expressing Mdrl acquire resistance against the lipophilic cations tetraphenylphosphonium (TPP+) and tetraphenylarsonium (TPA+), known substrates of P-gp (29) . Moreover (28) . Immunoblotting was carried out with the monoclonal antibody C219 and a secondary horseradish peroxidase-conjugated goat anti-mouse antibody. Mutagenesis. Competent E. coli UT5600 cells (500 l1) were spread on sterile 30 x 10 mm Petri dish on ice and exposed to UV light ('80 J/m2). Immediately after UV irradiation, cells were transformed with pBtac(phoA) and plated over LB plates containing 100 ug of ampicillin per ml and 200 ,g of X-P per ml.
Resistance Assays. Resistance of cells without plasmids or harboring pT7-5(lacY) or pT7-5(mdrl) against various compounds was assayed in both solid and liquid media. When tested on solid media, overnight cultures were diluted to an OD600 of 0.1 and grown at 30°C for a few hours. Cultures (200 ,ul; OD600 = 0.5) were mixed with 3 ml of soft agar (LB with 0.8% agar) at 45°C and poured over 1.5% agar LB square Petri dishes. Bistris propane (60 mM) was used to maintain pH 7.4 in experiments with chloroquine and quinidine. Fifteen minutes later, antibiotic filter disks were applied on each lawn, and the appropriate amount of tested antibiotic material was carefully loaded on each filter disk. Inhibition zones were measured after overnight growth at 30°C. When tested in liquid medium, overnight cultures were diluted into fresh LB containing ampicillin (100 ,xg/ml) and grown up to an OD600 of 0.6. Cells were then diluted again and aliquoted (50 ,ul) into 96-well microplates containing 50 /1 of various concentrations of the drugs. At the beginning of a typical experiment, the cell density (OD600 = 0.03) in the wells was measured in a microplate autoreader (model EL309; Bio-Tek, Burlington, VT). Plates were incubated at 30°C shaker, and cell density was monitored by following the absorption at 600 nm every 6 hr. Concentrations required to inhibit 50% of the growth (Dso) were determined. In experiments with chloroquine or quinidine, the LB medium was supplemented with 60 mM Bistris propane to maintain pH 7.4.
RESULTS
Construction of Leaky E. coli strains. We have observed previously that E. coli UT5600 (OmpT-) expresses Mdrl in a relatively stable state (28) . When Mdrl-alkaline phosphatase hybrids are analyzed by comparative immunoprecipitation experiments in E. coli UT5600 or CC181(OmpT+), it is apparent that the hybrids are expressed at a much higher level in the OmpT-strain (30) . Therefore Fig. 1B, EL) . In this study, alkaline phosphatase is used as the reporter (34) . Briefly, cells expressing native alkaline phosphatase grow as blue colonies on agar plates containing X-P. The blue hydrolysis product from X-P is insoluble and retained within the colonies. However, if the enzyme is able to diffuse away from the colonies into the agar, the blue product generated appears as a halo around the colonies (Fig. 1A) . To obtain leaky mutants, competent E. coli UT5600 cells were exposed to UV light and immediately transformed with a plasmid encoding alkaline phosphatase. Transformants were plated on agar containing 200 tjg of X-P per ml and 100 jig of ampicillin per ml. After an 18-hr incubation at 37°C, three colonies (UTL1, UTL2, and UTL3) of -10,000 transformants were found to form large blue halos (Fig. 1B) , indicating that alkaline phosphatase from these mutants is liberated into the medium.
Characterization of the Leaky Mutants. Mutations that cause significant alteration in the outer membrane permeability barrier result in leakage of periplasmic proteins into the medium (35) and in higher susceptibility to hydrophobic antibiotics (36) and detergents (37) . To examine the permeability of the outer membrane to hydrophobic agents, the sensitivity of the mutants to SDS or TPA+ was tested ( Fig. 2A) . As shown, the data demonstrate clearly that mutant UTL2 is significantly more sensitive to both compounds. In addition, by using a semiquantitative disk assay, the inhibition zones (clear halos) caused by the hydrophobic quinolone derivative nalidixic acid or by SDS are bigger with UTL2 than with wild-type UT5600 (Fig. 2B) . It is important to note that hydrophilic molecules such as EDTA cause similar growth inhibition zones with the wild-type and with the mutant UTL2 (Fig. 3B) . As a result of these experiments, UTL2 was chosen for further characterization.
E. coH UTL2 Cells Are Susceptible to the Toxic Effect of P-gp Related Agents. Wild-type E. coli is insensitive to most cancer drugs, probably because of the outer membrane permeability barrier. To examine cross-sensitivity of the leaky mutant to various cytotoxic agents that are substrates for P-gp, E. coli UT5600 and the permeable mutant UTL2 were exposed to various drugs using filter disks on agar plates (Fig. 3A) or in liquid media (Fig. 3B) Ds5 is the concentration needed to inhibit growth by 50%. It was calculated from triplicates of growth experiments as described in Fig.   2A , 3A, and 5.
on agar plates clearly demonstrate that UTL2 is significantly more sensitive to the toxic effect of chloroquine and quinidine and to a lesser extent to daunomycin (Fig. 3B) . High concentrations of verapamil are also more toxic to UTL2 than UT5600 (Fig. 3B) . By using a more quantitative growth analysis in liquid media, it is clear that UTL2 is also dramatically more sensitive to rhodamine, daunomycin, and puromycin (Fig. 3A) . The concentrations needed to inhibit growth by 50% (D50 values) are summarized in Table 1 . Other drugs such as doxorubicin, vinblastine, vincristine, actinomycin D, and colchicine have no effect on either E. coli UT5600 or UTL2 at the highest concentrations that can be tested (data not shown).
Expression of Mdrl in E. coli UTL2 Confers Multidrug
Resistance. An obvious prerequisite for P-gp studies is the ability of the mutant to express Mdrl to a level that is at least comparable to that observed in UT5600. Thus, membranes from E. coli UT5600 or UTL2 harboring pT7-5/mdrl were examined for Mdrl expression by Western blotting with anti-P-gp monoclonal antibody C219 (Fig. 4) . Surprisingly, the level of Mdrl in UTL2 cells is even higher (about 8-fold) than in UT5600. As of yet we do not know the reason for this improvement in the expression level of Mdrl in UTL2 cells. The higher level of Mdrl expression, though, enables the following investigation of Mdrl in UTL2. In a previous study (28) , it was suggested that mouse Mdrl is functional when expressed in E. coli. However, it was not possible to demonstrate Mdrl-mediated resistance to its known chemotherapeutic substrates in the heterologous system, mainly because of the impermeable outer membrane. This problem has now been resolved with the new leaky strain of E. coli UTL2. When UTL2 cells harboring pT7-5/mdrl or vector without mdrl, were exposed to various P-gp-related compounds in liquid medium (Fig. 5) , it is readily apparent that Mdrl confers significant resistance against quinidine, chloroquine, puromycin, and rhodamine (Fig. 5) (29) , because of the intrinsic resistance of E. coli to many substrates for P-gp. In the present study, we provide a strong indication that lack of toxicity of many P-gp substrates for E. coli is caused by low outer membrane permeability. By using the blue halo technique (34), E. coli mutants with enhanced outer membrane permeability were selected, and one mutant (UTL2) was found to be substantially more sensitive to P-gp substrates. This property has enabled us to study functional aspects of mouse Mdrl in E. coli using known P-gp substrates and modulators. The levels of resistance found in E. coli UTL2 expressing Mdrl are similar to those in resistant tumors in vivo, which are usually not more than 5-to 10-fold resistant. The concentrations of P-gp related drugs required to inhibit E. coli UTL2 growth are much higher than those required to inhibit growth of mammalian cells. It is possible therefore that Mdrl is unable to confer higher levels of resistance (similar to those in resistant cultured cell lines), because higher concentrations of the drugs are needed to inhibit growth of E. coli.
Among the various agents tested here, rhodamine (38) , puromycin (39, 40) , and daunomycin (41) are known P-gp substrates. Quinidine and chloroquine have been implicated in reversal of MDR phenomena only. Quinidine, an antiarrhythmic agent, is able to reverse P-gp-mediated resistance (18) . In addition, it has been demonstrated that quinidine binds specifically to membrane vesicles from multidrugresistant KB cells (42) and behaves as a competitive inhibitor of vinblastine uptake in inverted vesicles (43) . Therefore, it is not surprising that Mdrl confers quinidine resistance to E. coli, suggesting that the protein catalyzes export of the drug. However, unlike quinidine, chloroquine is only moderately effective in overcoming drug resistance. Chloroquine, a lysosomotropic amine, reverses drug resistance to anthracyclines and vinca alkaloids in multidrug-resistant cells (19, 44) . Although its ability to partially block doxorubicin efflux from resistant P388R cells is significant (45), chloroquine does not
labeling at concentrations that reverse multidrug resistance (46) . Consequently, it was suggested that chloroquine may not interact with P-gp but act in a different way to reverse multidrug resistance, possibly by influencing lysosomal integrity. In this study, however, we find that E. coli UTL2 is sensitive to chloroquine and that Mdrl confers chloroquine resistance. The observation suggests that chloroquine is probably a substrate for P-gp and may be translocated out of E. coli expressing Mdrl. In addition to conferring drug resistance, one important aspect of the P-gp problem is the ability to reverse multidrug resistance with chemosensitizers. Experiments with the leaky mutant of E. coli described here also demonstrate that reserpine, a potent P-gp modulator, abolishes drug resistance in UTL2 expressing mouse Mdrl. We also initiated experiments to test whether verapamil is able to reverse Mdrl-mediated drug resistance in E. coli. However, the concentration of verapamil needed to inhibit Mdrl in E. coli UTL2 is too high and causes inhibition of growth (data not shown). In resistant mammalian cells, the concentrations of verapamil needed to partially reverse 1-10 nM vinblastine uptake are in the micromolar range (i.e., '1000 times the concentration of vinblastine; ref. 41) . In E. coli, drug concentrations in the range of 10-100 tiM are needed to inhibit growth. Therefore, it is likely that toxic levels of verapamil are required for reversal.
The new expression system is potentially very powerful for large-scale screening of P-gp modulators on one hand and cytotoxic agents that are not recognized by P-gp on the other. The possibility of using known P-gp substrates in the heterologous expression system may open the way for structure/ function studies by site-directed mutagenesis and selection of intragenic suppressors, operations that can be accomplished considerably more efficiently in E. coli than in eukaryotes. Moreover 
